{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:52:47Z","timestamp":1778550767283,"version":"3.51.4"},"reference-count":43,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Background: The link between clinical recovery and immune restoration after severe COVID-19 remains poorly defined. Although most survivors experience symptomatic improvement, persistent symptoms have been hypothesized to reflect ongoing immune dysregulation. Methods: This prospective cohort study followed 93 unvaccinated adults with RT-PCR-confirmed moderate-to-critical COVID-19 at 3, 6, and 12 months post-discharge. Clinical assessments used structured interviews to evaluate the persistent symptoms. Peripheral blood analyses were used to measure lymphocyte subsets, immunoglobulins, and complement components. Results: Clinical recovery was substantial; fatigue prevalence declined from 70.9% to 24.7% and dyspnea prevalence from 81.7% to 25.8% by 12 months (p &lt; 0.001 for both). However, immune recovery exhibited divergent patterns. Activated T cells (CD3+HLA-DR+) decreased significantly (from 20% to 13%; p &lt; 0.001), complement C3c levels paradoxically increased from 1.23 to 1.35 g\/L (p &lt; 0.001), and serum IgA increased by 32% (p = 0.003). NK cells remained stable overall but were persistently reduced in a subset (~25%) of patients, particularly among those with fatigue and dyspnea. Critical illness was associated with slower T-cell resolution, prolonged IgM elevation, and increased complement activity. Conclusions: One year after hospitalization, most patients achieved substantial clinical improvement, but immune reconstitution lagged behind. These findings highlight the dissociation between clinical and immunological recovery and suggest that persistent immune dysregulation may be associated with long COVID manifestations. Incorporating immune monitoring into post-COVID care may help identify patients at risk of prolonged sequelae and guide targeted therapeutic strategies.<\/jats:p>","DOI":"10.3390\/v17121610","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T15:27:20Z","timestamp":1765553240000},"page":"1610","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and Immunological Recovery Trajectories in Severe COVID-19 Survivors: A 12-Month Prospective Follow-Up Study"],"prefix":"10.3390","volume":"17","author":[{"given":"Edita","family":"Strumiliene","sequence":"first","affiliation":[{"name":"Clinic of Infectious Diseases and Dermatovenerology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3255-7669","authenticated-orcid":false,"given":"Laura","family":"Malinauskiene","sequence":"additional","affiliation":[{"name":"Clinic of Chest Diseases, Immunology and Allergology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurgita","family":"Urboniene","sequence":"additional","affiliation":[{"name":"Centre of Infectious Diseases, Vilnius University Hospital Santaros Klinikos, LT-08406 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laimut\u0117","family":"Jurgauskien\u0117","sequence":"additional","affiliation":[{"name":"Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birut\u0117","family":"Zablockien\u0117","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases and Dermatovenerology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6488-6312","authenticated-orcid":false,"given":"Ligita","family":"Jancoriene","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases and Dermatovenerology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A Clinical Case Definition of Post-COVID-19 Condition by a Delphi Consensus","volume":"22","author":"Soriano","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: Major Findings, Mechanisms and Recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact","volume":"38","author":"Davis","year":"2021","journal-title":"eClinicalMedicine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal Analyses Reveal Immunological Misfiring in Severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/all.15372","article-title":"T-Cell Recovery and Evidence of Persistent Immune Activation 12 Months After Severe COVID-19","volume":"77","author":"Taeschler","year":"2022","journal-title":"Allergy"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S0140-6736(23)00810-3","article-title":"6-Month Consequences of COVID-19 in Patients Discharged from Hospital: A Cohort Study","volume":"401","author":"Huang","year":"2023","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(21)01755-4","article-title":"1-Year Outcomes in Hospital Survivors with COVID-19: A Longitudinal Cohort Study","volume":"398","author":"Huang","year":"2021","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejim.2021.06.009","article-title":"Prevalence of Post-COVID-19 Symptoms in Hospitalized and Non-Hospitalized COVID-19 Survivors: A Systematic Review and Meta-Analysis","volume":"92","author":"Florencio","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.mayocp.2021.04.024","article-title":"Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort","volume":"96","author":"Vanichkachorn","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(21)00174-0","article-title":"3-Month, 6-Month, 9-Month, and 12-Month Respiratory Outcomes in Patients Following COVID-19-Related Hospitalization: A Prospective Study","volume":"9","author":"Wu","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41577-021-00665-1","article-title":"The State of Complement in COVID-19","volume":"22","author":"Afzali","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"108598","DOI":"10.1016\/j.clim.2020.108598","article-title":"Complement C3 vs C5 Inhibition in Severe COVID-19: Early Clinical Findings Reveal Differential Biological Efficacy","volume":"220","author":"Mastellos","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"eabd2223","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA Dominates the Early Neutralizing Antibody Response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"eabe5511","DOI":"10.1126\/sciimmunol.abe5511","article-title":"Persistence of Serum and Saliva Antibody Responses to SARS-CoV-2 Spike Antigens in COVID-19 Patients","volume":"5","author":"Isho","year":"2020","journal-title":"Sci. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sousa, G.F., Carpes, R.M., Silva, C.A.O., Pereira, M.E.P., Silva, A.C.V.F., Coelho, V.A.G.S., Costa, E.P., Mury, F.B., Gestinari, R.S., and Souza-Menezes, J. (2023). Immunoglobulin A as a Key Immunological Molecular Signature of Post-COVID-19 Conditions. Viruses, 15.","DOI":"10.3390\/v15071545"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41385-022-00511-0","article-title":"Systemic and Mucosal IgA Responses Are Variably Induced in Response to SARS-CoV-2 mRNA Vaccination and Are Associated with Protection Against Subsequent Infection","volume":"15","author":"Isho","year":"2022","journal-title":"Mucosal Immunol."},{"key":"ref_18","unstructured":"World Health Organization (WHO) (2025, December 09). Coronavirus Disease (COVID-19): Post COVID-19 Condition. Available online: https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/coronavirus-disease-(covid-19)-post-covid-19-condition."},{"key":"ref_19","unstructured":"World Health Organization (WHO) (2025, December 09). Obesity and Overweight. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"World Medical Association (2013). Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA, 310, 2191\u20132194.","DOI":"10.1001\/jama.2013.281053"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(22)00126-6","article-title":"Health Outcomes in People 2 Years After Surviving Hospitalization with COVID-19: A Longitudinal Cohort Study","volume":"10","author":"Huang","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_22","first-page":"82","article-title":"Long COVID-19: A Systematic Review","volume":"71","author":"Karuturi","year":"2023","journal-title":"J. Assoc. Physicians India"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cortex.2025.07.005","article-title":"Functional Connectivity Changes in Long-Covid Patients with and without Cognitive Impairment","volume":"191","author":"Leitner","year":"2025","journal-title":"Cortex"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41591-022-01909-w","article-title":"Symptoms and Risk Factors for Long COVID in Non-Hospitalized Adults","volume":"28","author":"Subramanian","year":"2022","journal-title":"Nat. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"105792","DOI":"10.1016\/j.ebiom.2025.105792","article-title":"Symptoms and Pathophysiology of Post-Acute Sequelae Following COVID-19 (PASC): A Cohort Study","volume":"117","author":"Robineau","year":"2025","journal-title":"eBioMedicine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.immuni.2022.08.008","article-title":"SARS-CoV-2-Specific T Cells in the Changing Landscape of the COVID-19 Pandemic","volume":"55","author":"Bertoletti","year":"2022","journal-title":"Immunity"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41590-023-01724-6","article-title":"Long COVID Manifests with T Cell Dysregulation, Inflammation and an Uncoordinated Adaptive Immune Response to SARS-CoV-2","volume":"25","author":"Yin","year":"2024","journal-title":"Nat. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/s41467-023-37368-1","article-title":"Post-Acute Sequelae of COVID-19 Is Characterized by Diminished Peripheral CD8+\u03b27 Integrin+ T Cells and Anti-SARS-CoV-2 IgA Response","volume":"14","author":"Oliveira","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e85009","DOI":"10.7554\/eLife.85009","article-title":"Prolonged T-Cell Activation and Long COVID Symptoms Independently Associate with Severe COVID-19 at 3 Months","volume":"12","author":"Santopaolo","year":"2023","journal-title":"eLife"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.immuni.2021.09.002","article-title":"Early IFN-\u03b1 Signatures and Persistent Dysfunction Are Distinguishing Features of NK Cells in Severe COVID-19","volume":"54","author":"Knoll","year":"2021","journal-title":"Immunity"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"eabd6832","DOI":"10.1126\/sciimmunol.abd6832","article-title":"Natural Killer Cell Immunotypes Related to COVID-19 Disease Severity","volume":"5","author":"Maucourant","year":"2020","journal-title":"Sci. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jaci.2021.07.022","article-title":"Abnormality in the NK-Cell Population Is Prolonged in Severe COVID-19 Patients","volume":"148","author":"Leem","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e188182","DOI":"10.1172\/JCI188182","article-title":"Long COVID Is Associated with Lower Percentages of Mature, Cytotoxic NK Cell Phenotypes","volume":"135","author":"Tsao","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"25018","DOI":"10.1073\/pnas.2010540117","article-title":"Systemic Complement Activation Is Associated with Respiratory Failure in COVID-19 Hospitalized Patients","volume":"117","author":"Holter","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.4049\/jimmunol.2000644","article-title":"COVID-19: Complement, Coagulation, and Collateral Damage","volume":"205","author":"Lo","year":"2020","journal-title":"J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"eadg7942","DOI":"10.1126\/science.adg7942","article-title":"Persistent Complement Dysregulation with Signs of Thromboinflammation in Active Long Covid","volume":"383","author":"Hoch","year":"2024","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cca.2020.04.026","article-title":"IgA-Ab Response to Spike Glycoprotein of SARS-CoV-2 in Patients with COVID-19: A Longitudinal Study","volume":"507","author":"Padoan","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/infdis\/jiae447","article-title":"Early, Robust Mucosal Secretory Immunoglobulin A but Not Immunoglobulin G Response to Severe Acute Respiratory Syndrome Coronavirus 2 Spike in Oral Fluid Is Associated with Faster Viral Clearance and Coronavirus Disease 2019 Symptom Resolution","volume":"231","author":"Pisanic","year":"2025","journal-title":"J. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Baraniuk, J.N., Eaton-Fitch, N., and Marshall-Gradisnik, S. (2024). Meta-Analysis of Natural Killer Cell Cytotoxicity in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1440643"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13643-019-1202-6","article-title":"A Systematic Review of Natural Killer Cells Profile and Cytotoxic Function in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"8","author":"Cabanas","year":"2019","journal-title":"Syst. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","article-title":"Dubbo Infection Outcomes Study Group. Post-Infective and Chronic Fatigue Syndromes Precipitated by Viral and Non-Viral Pathogens: Prospective Cohort Study","volume":"333","author":"Hickie","year":"2006","journal-title":"BMJ"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1067\/mai.2003.1615","article-title":"Complement Activation in a Model of Chronic Fatigue Syndrome","volume":"112","author":"Sorensen","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1001\/archinternmed.2009.384","article-title":"Mental Morbidities and Chronic Fatigue in Severe Acute Respiratory Syndrome Survivors: Long-Term Follow-Up","volume":"169","author":"Lam","year":"2009","journal-title":"Arch. Intern. Med."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/12\/1610\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T15:29:22Z","timestamp":1765553362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/12\/1610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["v17121610"],"URL":"https:\/\/doi.org\/10.3390\/v17121610","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]}}}